NEW YORK (GenomeWeb) – BG Medicine has entered in financing agreements for $2.5 million, the company disclosed in a document filed with the US Securities and Exchange Commission on Tuesday.

The firm entered into a securities purchase agreement with its principal shareholders Applied Genomic Technology Capital Fund, AGTC Advisors Fund, and Flagship Ventures Fund, under which BG Medicine sold secured convertible promissory notes totaling $500,000. 

Additionally, BG Medicine has agreed to sell to the purchasers $2 million of newly created Series A preferred stock. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.